/Companies

Balance Ophthalmics

Sioux Falls, US · Founded 2023 · Delaware corporation

Find your way into Balance Ophthalmics

Sign up to see every warm intro you have to Balance Ophthalmics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Balance Ophthalmics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Balance Ophthalmics develops ophthalmic medical technology for treating glaucoma, offering a non-pharmaceutical, non-surgical therapy that lowers intraocular pressure while patients sleep. Its products are intended for eye care professionals and glaucoma patients.

Founders & leadership

Balance Ophthalmics was founded in 2023 by John Berdahl.

JB
John BerdahlFounder
SJSeph Jensen
Seph JensenCEOSeph Jensen is an executive with experience across multiple board and C-suite roles in the eyecare industry, including responsibility for commercial strategy, cost management, and public company operations.

Board

AB
Alison BauerleinBoard director
PP
Philip PhillipsBoard director
ML
Matt LarsonBoard director
SR
Stuart RaetzmanBoard director

Reported raises · per SEC filings

Form D private placements

$5.7M disclosed across 2 rounds · 2023–2024

▶$3.7MraisedOct 2024 · 29 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Seph JensenExecutive Officer, Director
  • Alison BauerleinDirector
  • John BerdahlExecutive Officer, Director
  • Philip PhillipsDirector
  • Matt LarsonDirector
  • Stuart RaetzmanDirector
Offering amount
$3.7M
Amount sold
$3.7M
Minimum investment
$100K
First sale
Sep 2024
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedAug 2023 · 8 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Philip PhillipsDirector
  • John BerdahlExecutive Officer, Director
  • Matt LarsonDirector
  • Stuart RaetzmanDirector
  • Seph JensenExecutive Officer, Director
Offering amount
$3M
Amount sold
$2M
Minimum investment
$10K
First sale
Jul 2023
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

Companies working in the same space as Balance Ophthalmics.

Frequently asked questions

What does Balance Ophthalmics do?
Balance Ophthalmics develops ophthalmic medical technology for treating glaucoma, offering a non-pharmaceutical, non-surgical therapy that lowers intraocular pressure while patients sleep. Its products are intended for eye care professionals and glaucoma patients.
Who founded Balance Ophthalmics?
Balance Ophthalmics was founded by John Berdahl in 2023.
How much funding has Balance Ophthalmics raised?
Balance Ophthalmics has disclosed $5.7M raised across 2 rounds.
Where is Balance Ophthalmics headquartered?
Balance Ophthalmics is headquartered in Sioux Falls, US.